The global Xdr-Tb Treatment Market is expanding steadily as a result of rising surveillance, expanding rapid molecular diagnostic capacity, and a shift toward standardized, all-oral short-course therapeutic regimens (such as BPaLM). Growth is further driven by international grants, government-led elimination programs, and targeted pricing reductions for advanced antimicrobial therapeu... https://www.databridgemarketresearch.com/